GlassScriptPhysician profile
Matthew C Maruska
NPI 1164717963
$2,583.40
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $461 · 2021: $512 · 2022: $158 · 2023: $86.00 · 2024: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $622 · Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $622.18 |
| Food and Beverage | $548.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,089.60 | 2019-2024 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $383.95 | 2019-2021 | |
| Amgen INC. | $211.31 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $191.18 | 2019-2022 | |
| Radius Health, INC. | $99.63 | 2019-2021 | |
| Depuy Synthes Sales INC. | $79.36 | 2019-2022 | |
| Bioventus LLC | $77.42 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Ge Healthcare | $71.92 | 2024 | |
| Stryker Corporation | $59.21 | 2020 | |
| Orthogenrx INC. | $55.70 | 2019 | |
| Horizon Therapeutics Plc | $49.64 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $36.11 | 2021-2023 | Xiaflex |
| Molnlycke Health Care US, LLC | $32.44 | 2022-2024 | Mepilex Border Post-Op Ag, Avance |
| Ethicon US, LLC | $28.37 | 2022 | |
| Nevro Corp. | $26.79 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $26.31 | 2022 | |
| Baudax Bio INC. | $18.98 | 2020 | |
| Heron Therapeutics, INC. | $17.37 | 2021 | |
| Vericel Corporation | $14.71 | 2022 | |
| Avanos Medical | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Maruska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.